Literature DB >> 36117926

Role of insulin action in the pathogenesis of diabetic complications.

Kyoichiro Tsuchiya1.   

Abstract

Among the various pathological conditions associated with type 2 diabetes, insulin resistance has long been reported to be a potent risk factor for diabetic complications. The liver, skeletal muscle, and adipose tissue are the major organs of action of insulin in systemic glucose metabolism, but insulin receptors and their downstream insulin signaling molecules are also constitutively expressed in vascular endothelial cells, vascular smooth muscle, and monocytes/macrophages. Forkhead box class O family member proteins (FoxOs) of transcription factors are essential regulators of cellular homeostasis, including glucose and lipid metabolism, oxidative stress response and redox signaling, cell cycle progression and apoptosis. In vascular endothelial cells, FoxOs strongly promote atherosclerosis via suppressing nitric oxide production and enhancing inflammatory responses. In liver sinusoidal endothelial cells, FoxOs induces hepatic insulin resistance by inducing nitration of insulin receptor in hepatocytes. Insulin resistance in adipose tissue limits capacity of lipid accumulation in adipose tissue, which promotes ectopic lipid accumulation and organ dysfunction in liver, vascular, and kidney. Modulation of insulin sensitivity in adipose tissue to induce healthy adipose expansion is expected to be a promising strategy for diabetic complications. © The Japan Diabetes Society 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Entities:  

Keywords:  Adipose tissue; Fatty liver; FoxOs; Insulin resistance

Year:  2022        PMID: 36117926      PMCID: PMC9477992          DOI: 10.1007/s13340-022-00601-1

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  60 in total

1.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

2.  FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.

Authors:  Min Zhu; Qing-Jun Zhang; Lin Wang; Hao Li; Zhi-Ping Liu
Journal:  Atherosclerosis       Date:  2011-10-02       Impact factor: 5.162

3.  Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.

Authors:  Michiko Itoh; Takayoshi Suganami; Nobutaka Nakagawa; Miyako Tanaka; Yukio Yamamoto; Yasutomi Kamei; Shuji Terai; Isao Sakaida; Yoshihiro Ogawa
Journal:  Am J Pathol       Date:  2011-09-07       Impact factor: 4.307

4.  Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

Authors:  Seongah Han; Chien-Ping Liang; Tracie DeVries-Seimon; Mollie Ranalletta; Carrie L Welch; Kadesha Collins-Fletcher; Domenico Accili; Ira Tabas; Alan R Tall
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

5.  Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.

Authors:  Julia Baumgartl; Stephanie Baudler; Maximilian Scherner; Vladimir Babaev; Liza Makowski; Jill Suttles; Marcia McDuffie; Kazuyuki Tobe; Takashi Kadowaki; Sergio Fazio; C Ronald Kahn; Gökhan S Hotamisligil; Wilhelm Krone; Macrae Linton; Jens C Brüning
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

6.  The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance.

Authors:  David Vicent; Jacob Ilany; Tatsuya Kondo; Keiko Naruse; Simon J Fisher; Yaz Y Kisanuki; Sven Bursell; Masashi Yanagisawa; George L King; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects.

Authors:  L Frittitta; G Grasso; M E Munguira; R Vigneri; V Trischitta
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

8.  Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan.

Authors:  A Sekikawa; M Tominaga; K Takahashi; H Eguchi; M Igarashi; H Ohnuma; K Sugiyama; H Manaka; H Sasaki; H Fukuyama
Journal:  Diabetes Care       Date:  1993-04       Impact factor: 19.112

9.  Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice.

Authors:  Kentaro Mori; Kyoichiro Tsuchiya; Suguru Nakamura; Yasutaka Miyachi; Kumiko Shiba; Yoshihiro Ogawa; Kenichiro Kitamura
Journal:  Cardiovasc Diabetol       Date:  2019-06-24       Impact factor: 9.951

10.  Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice.

Authors:  Hideyuki Okuma; Kentaro Mori; Suguru Nakamura; Tetsuo Sekine; Yoshihiro Ogawa; Kyoichiro Tsuchiya
Journal:  Int J Mol Sci       Date:  2021-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.